Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 37%
Hold 21%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is a leader in the hospital industry with a strong management team, consistent growth trends, and impressive margins. The company's strong track record of operational performance and continued market share gains in faster-growing markets make it a premier healthcare provider. Factors such as state supplemental payments and tracking of unpaid premiums from exchange patients further support our positive outlook on the company. Our price target of $520 reflects a premium valuation, but is supported by the company's strong fundamentals, including a diverse board and workforce and a focus on sustainability. Higher-than-expected approvals for state-directed payments and continued cost controls could provide further upside to our target price.

Bears say

HCA Healthcare is facing several challenges, including a recent decline in same-facility admissions and outpatient surgeries, primarily due to the impact of weather and respiratory illnesses. The company's financials were also affected by changes in state supplemental payments and weaker respiratory season. Additionally, HCA Healthcare may face pressure from increased competition and tightening labor markets in certain regions. These factors contribute to the negative outlook on the stock's performance.

HCA Healthcare (HCA) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 37% recommend Buy, 21% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 19 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $523.68, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $523.68, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.